HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Mori Selected Research

Iodothyronine Deiodinase Type II

7/2001Expression and regulation of type II iodothyronine deiodinase in human thyroid gland.
11/2000Expression of type II iodothyronine deiodinase in brain tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Mori Research Topics

Disease

87Neoplasms (Cancer)
01/2022 - 01/2000
28Carcinoma (Carcinomatosis)
02/2015 - 01/2000
18Neoplasm Metastasis (Metastasis)
04/2018 - 01/2000
16Stomach Neoplasms (Stomach Cancer)
01/2015 - 01/2000
16Infections
11/2011 - 01/2000
14Breast Neoplasms (Breast Cancer)
01/2017 - 02/2000
14Colorectal Neoplasms (Colorectal Cancer)
07/2015 - 07/2000
14Lymphatic Metastasis
08/2011 - 07/2000
12Inflammation (Inflammations)
10/2020 - 06/2000
12Guillain-Barre Syndrome
10/2011 - 02/2000
11Hepatocellular Carcinoma (Hepatoma)
01/2019 - 04/2000
11Esophageal Neoplasms (Esophageal Cancer)
07/2018 - 02/2001
9Carcinogenesis
01/2017 - 06/2000
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2001
8Multiple Sclerosis
11/2020 - 10/2000
8Asthma (Bronchial Asthma)
02/2014 - 06/2000
8Body Weight (Weight, Body)
11/2013 - 07/2000
7Adenocarcinoma
06/2022 - 07/2000
7Esophageal Squamous Cell Carcinoma
11/2017 - 09/2000
7Pancreatic Neoplasms (Pancreatic Cancer)
10/2014 - 11/2002
7Obesity
11/2013 - 02/2001
7Fibrosis (Cirrhosis)
02/2012 - 02/2000
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2004 - 09/2000
6Chronic Hepatitis C
09/2001 - 01/2000
5Colonic Neoplasms (Colon Cancer)
11/2021 - 05/2000
5Pulmonary Tuberculosis
01/2015 - 01/2000
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2012 - 02/2000
5Necrosis
02/2009 - 08/2000
4Disease Progression
10/2020 - 09/2000
4Rheumatoid Arthritis
03/2019 - 05/2000
4Insulin Resistance
07/2018 - 03/2006
4Type 2 Diabetes Mellitus (MODY)
10/2016 - 01/2000
4Prostatic Neoplasms (Prostate Cancer)
02/2014 - 03/2004
4Lung Neoplasms (Lung Cancer)
11/2013 - 11/2000
4Amyloidosis
06/2011 - 09/2000
4Atherosclerosis
12/2010 - 01/2000
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2009 - 09/2001
4Hemorrhage
11/2007 - 05/2003
4Lymphoma (Lymphomas)
12/2001 - 04/2001
4Adenoma (Adenomas)
09/2001 - 07/2000
4Leukemia
07/2001 - 08/2000
3Neuromyelitis Optica (Devic's Disease)
11/2020 - 05/2010
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 04/2013
3Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
11/2017 - 01/2001
3Brain Neoplasms (Brain Tumor)
04/2015 - 11/2000

Drug/Important Bio-Agent (IBA)

28Messenger RNA (mRNA)IBA
06/2009 - 01/2000
21Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2000
11Pharmaceutical PreparationsIBA
07/2018 - 08/2000
10Fluorouracil (Carac)FDA LinkGeneric
04/2018 - 01/2000
10CytokinesIBA
01/2018 - 01/2000
10AntibodiesIBA
01/2017 - 02/2000
10DNA (Deoxyribonucleic Acid)IBA
01/2015 - 10/2000
9Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2001
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2006 - 02/2000
8Cisplatin (Platino)FDA LinkGeneric
04/2018 - 01/2000
8Indicators and Reagents (Reagents)IBA
05/2015 - 03/2001
8InterferonsIBA
11/2010 - 02/2000
8AntigensIBA
03/2003 - 02/2000
7EnzymesIBA
12/2017 - 02/2000
7Amantadine (Aman)FDA LinkGeneric
05/2005 - 10/2000
6Biological ProductsIBA
11/2009 - 02/2001
6Matrix Metalloproteinases (MMPs)IBA
02/2006 - 03/2000
6Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2001 - 02/2000
5LigandsIBA
01/2019 - 07/2000
5Docetaxel (Taxotere)FDA Link
04/2018 - 07/2001
5LipidsIBA
12/2017 - 01/2000
5MicroRNAs (MicroRNA)IBA
07/2015 - 01/2008
5LeptinIBA
11/2013 - 03/2001
5Carcinoembryonic AntigenIBA
03/2013 - 06/2000
5Immunoglobulin E (IgE)IBA
12/2011 - 04/2003
5Immunoglobulin G (IgG)IBA
05/2003 - 10/2000
5Peptides (Polypeptides)IBA
08/2001 - 03/2000
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 04/2000
4Insulin (Novolin)FDA Link
12/2016 - 07/2000
4Adrenal Cortex Hormones (Corticosteroids)IBA
02/2012 - 02/2000
4Apolipoprotein A-II (Apolipoprotein A2)IBA
06/2011 - 09/2000
4Interferon-alpha (Interferon Alfa)IBA
05/2009 - 01/2000
4beta CateninIBA
05/2009 - 12/2004
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2009 - 07/2000
4Oxygen (Dioxygen)IBA
01/2008 - 10/2000
4Etoposide (VP 16)FDA LinkGeneric
09/2001 - 04/2000
4Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2001 - 06/2000
4Codon (Codons)IBA
06/2001 - 05/2000
3ThrombomodulinIBA
01/2018 - 12/2001
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 01/2000
3Glutamine (L-Glutamine)FDA Link
07/2015 - 01/2000
3CreatinineIBA
06/2015 - 05/2000
3Phenobarbital (Luminal)FDA Link
04/2015 - 06/2000
3GemcitabineFDA Link
07/2013 - 08/2006
3Monoclonal AntibodiesIBA
04/2013 - 08/2000

Therapy/Procedure

42Therapeutics
01/2022 - 01/2000
17Drug Therapy (Chemotherapy)
01/2022 - 01/2000
5Neoadjuvant Therapy
06/2022 - 01/2000
5Immunotherapy
01/2022 - 03/2000
4Radiotherapy
04/2018 - 04/2000
4Lasers (Laser)
10/2014 - 07/2000
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2013 - 01/2001
3Liver Transplantation
11/2020 - 11/2000
3Esophagectomy
07/2018 - 11/2012
3Aftercare (After-Treatment)
01/2016 - 06/2000